Gsk Share Discussion Threads

[markbelluk] 02/5/2021 09:18

3% only if held in one fund. They have multiple funds

[whatsup32] 02/5/2021 09:00

He has to report if his holding is over 3%. Two Billion pounds equates to roughly 3%. His holding is reported to be multi billion (suggesting £3B+) that is nearly three weeks ago.

[spud] 02/5/2021 08:42

Probably because if he is building a stake, by announcing it, he'd put the price up on himself.spud

[whatsup32] 02/5/2021 08:30

I read today’s Sunday Times article , front page main head line on business section regurgitating same old. Question that still needs to be asked and has not been answered if Elliott has a substantial holding then why has it not been declared .

‘Elliott was reported to have built a multi Billion pound stake last month’ ST. Article quote

[daneswooddynamo] 02/5/2021 08:06

Maybe q2 2022 if that’s when the split comes

[spud] 02/5/2021 07:30

Well I gave my prediction some time ago on this board that EW would be shoulder barged during Q2 and I still stand by that.It might be that she is put into dry storage for the future potential heading up of the CD, but if that turns out to be the case, then I don't envisage seeing the dust wraps ever coming off again.spud

[alex1621] 02/5/2021 06:32

Sunday Times running a piece on GSK. Headline "Times running out for Glaxo boss". Suggests that there's not a lot of shareholder support for EW, with some reaching out to Elliot. AGM next week.

[daneswooddynamo] 01/5/2021 07:19

TM quite correct, 3 percent is threshold for U.K. incorporated issuer trading on a regulated U.K. exchange. Two days to inform issuer ( and LSE ) and issuer has one day to notify market

[tradermichael] 01/5/2021 07:07

Could be a good time for an IPO, rather than a straight 'split' ......

Britain is set to enjoy its biggest economic boom since the aftermath of the Second World War, a top banking boss has predicted.

Jes Staley, chief executive of Barclays, has forecast the country is poised for a “spectacular” recovery due to “tremendous pent-up demand”.
He cited the vaccine rollout and an estimated £200billion of savings that households have amassed in the lockdowns. The Bank of England is expected to hike annual growth forecasts next week.

Mr Staley said: “Our economic forecast is for the UK economy to grow by 6.5% this year – that’s the strongest growth rate in the British economy since 1948. That’s pretty spectacular.”
Growth of 6.5% would equate to a £136bn boost for the economy, the New Economics Foundation said, and £27bn extra in taxes for the Treasury.

[tradermichael] 01/5/2021 07:06

Well, the rules cite the 'issuer'. Notification at 3% for a UK issuer, 5% for a non-UK issuer.

[sawney] 01/5/2021 05:13

Happy to be corrected but as I understand it....3% reporting threshold is for buyers within the UK...
5% for buyers outside the UK....

[abdullla] 30/4/2021 15:28

Pension funds are selling but who is buying?

[grahamburn] 30/4/2021 14:34

He didn't when he joined some 10 years ago.

GSK may just be another long term project and not a get-rich-quick scheme for Elliot (or anyone else).

[meijiman] 30/4/2021 14:28

Difference is that Soriot had a pipeline and a timetable which was deliverable.
Don't think Elliot will get too excited by that new range of glossy lipsticks.
The delivery has to be on the pharma side.

[poikka] 30/4/2021 12:40

Reaching out for 1350, but will it break through and stay through..

I see that Soirot is starting to fight back, saying that 90% of the vaccines in India were from AZN and 98% of the vaccines in Covax.

Really, the EU commission and some EU leaders should hang their heads in shame.

[alex1621] 30/4/2021 12:19

I didn't say that GSK and AZN were equivalent? My point was that before the Pfizer bid it was under the cosh, like GSK. AZN was going through a similar malaise to GSK currently. Then it lit up with the Pfizer bid, and the pressure was on Soriot to persuade shareholders to back his pipeline plans. The question I was pondering was whether EW would get similar backing? On 23 June we will learn what the management view is of the pipeline ... if it's not impressive then I think all or part of GSK will be in play.

[daneswooddynamo] 30/4/2021 10:50

Indeed its demise is much exaggerated, I would just focus on the fact that Elliott has jumped aboard as they think it is an attractive entry point and either heads they win if the split/pipe delivers, tails they might be able to agitate/extract value if it continues to disappoint

[whatsup32] 30/4/2021 10:40

Regardless of Elliott, happy to hold on to GSK , solid company in uncertain times

[spoole5] 30/4/2021 10:19

Yes, gsk is a mismatch of parts, all of which will be better off being part of other more focused businesses.

[porsche1945] 30/4/2021 09:57

2alex

Astra was nothing like gsk, gsk has a poor pipeline of drugs and little oncology which is where Astra specialise and it’s where all the big money is. Gsk is only worth more in bits and hopefully that’s what Paul Singer has in mind, break it up and sell it off and EW can go back to selling lipstick.

[spyder] 30/4/2021 09:55

I’m certain the story is correct or a retraction would have had to be issued, and GSK themselves acknowledged Elliott’s involvement.
What is curios is that the FT quote a ‘multi billion pound investment’ - in my mind multi billion means more than 3 billion?? Certainly it must mean more than 2 billion.
With the market cap of GSK currently at £67.4bn, then 3% would be £2.02bn, so if the ‘multi billion’ reference is correct, they must have >3% and it is odd that it has not yet been declared.
Perhaps the situation is that Elliott ‘are building a multi billion’ stake but has not got there yet? Or the stake is held partly/fully in non-declarable derivatives? They certainly exist as I think I’m right in saying that was what went wrong at Archegos?

[whatsup32] 30/4/2021 09:08

3% is the reporting point for shareholders. Above that it has to be declared, I imagine Elliott has not got to that level since his supposed stake building was some 2 weeks ago it raises questions as to his involvement in GSK

[alex1621] 30/4/2021 08:54

It wasn't not so long ago the AZN share price was languishing and Soriot then had to fight off a takeover from Pfizer. He argued that the drug pipeline would soon pay off and shareholders backed him. The situation at GSK seems vaguely similar. I wonder how EW would fare in a similar situation?

[spud] 30/4/2021 07:17

What a difference a Captain at the helm makes....spud